Back to top

Major Investor Makes Bold Exit Move in Enliven Therapeutics Stock

New insider activity at Enliven Therapeutics ( ($ELVN) ) has taken place on June 24, 2026. Orbimed Advisors LLC, a significant shareholder in Enliv...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enliven Therapeutics, Inc. (ELVN)